Thursday, July 16, 2009

[EQ] Social inequalities in mortality: a problem of cognitive function?

Social inequalities in mortality: a problem of cognitive function?

Michael Marmot* and Mika Kivimäki
Department of Epidemiology and Public Health, University College London, UK
European Heart Journal Advance Access published online on July 14, 2009
European Heart Journal, doi:10.1093/eurheartj/ehp264

 

Available online at : http://eurheartj.oxfordjournals.org/cgi/reprint/ehp264v1

This editorial refers to ‘Does IQ explain socio-economic differentials in total and cardiovascular disease mortality? Comparison with the explanatory power of traditional cardiovascular disease risk factors in the Vietnam Experience Study’{dagger}, by G.D. Batty et al., on page 1903


Does IQ explain socio-economic differentials in total and cardiovascular disease mortality?
Comparison with the explanatory power of traditional cardiovascular disease risk factors in the Vietnam Experience Study


G. David Batty1,2,3,*, Martin J. Shipley4, Ruth Dundas1, Sally Macintyre1, Geoff Der1, Laust H. Mortensen5,6 and Ian J. Deary2

1 Medical Research Council Social and Public Health Sciences Unit, University of Glasgow, UK
2 Department of Psychology, MRC Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
3 The George Institute for International Health, University of Sydney, Sydney, Australia
4 Department of Epidemiology and Public Health, University College London, London, UK
5 National Institute of Public Health, University of Southern Denmark, Copenhagen, DK
6 Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA

Available online at:
http://eurheartj.oxfordjournals.org/cgi/content/full/ehp254v1?ijkey=67c476f65760629157c80fea8825464bf797c952

Aims: The aim of this study was to examine the explanatory power of intelligence (IQ) compared with traditional cardiovascular disease (CVD) risk factors in the relationship of socio-economic disadvantage with total and CVD mortality, that is the extent to which IQ may account for the variance in this well-documented association.

Methods and results: Cohort study of 4289 US male former military personnel with data on four widely used markers of socio-economic position (early adulthood and current income, occupational prestige, and education), IQ test scores (early adulthood and middle-age), a range of nine established CVD risk factors (systolic and diastolic blood pressure, total blood cholesterol, HDL cholesterol, body mass index, smoking, blood glucose, resting heart rate, and forced expiratory volume in 1 s), and later mortality. We used the relative index of inequality (RII) to quantify the relation between each index of socio-economic position and mortality. Fifteen years of mortality surveillance gave rise to 237 deaths (62 from CVD and 175 from ‘other’ causes). In age-adjusted analyses, as expected, each of the four indices of socio-economic position was inversely associated with total, CVD, and ‘other’ causes of mortality, such that elevated rates were evident in the most socio-economically disadvantaged men. When IQ in middle-age was introduced to the age-adjusted model, there was marked attenuation in the RII across the socio-economic predictors for total mortality (average 50% attenuation in RII), CVD (55%), and ‘other’ causes of death (49%). When the nine traditional risk factors were added to the age-adjusted model, the comparable reduction in RII was less marked than that seen after IQ adjustment: all-causes (40%), CVD (40%), and ‘other’ mortality (43%). Adding IQ to the latter model resulted in marked, additional explanatory power for all outcomes in comparison to the age-adjusted analyses: all-causes (63%), CVD (63%), and ‘other’ mortality (65%). When we utilized IQ in early adulthood rather than middle-age as an explanatory variable, the attenuating effect on the socio-economic gradient was less pronounced although the same pattern was still present.

Conclusion: In the present analyses of socio-economic gradients in total and CVD mortality, IQ appeared to offer greater explanatory power than that apparent for traditional CVD risk factors.

 

 

 *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMS Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.

------------------------------------------------------------------------------------
PAHO/WHO Website


Follow us on Twitter: http://twitter.com/eqpaho


Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.  

[EQ] Testing Times in Russia: How to facilitate access to essential drugs and get more value out of pharmaceutical expenditures?

Testing Times in Russia:
How to facilitate access to essential drugs and get more value out of pharmaceutical expenditures?

 

The World Bank in Russia - Russian Economic Report
From Crisis to Recovery – June 2009

 

Available online as PDF file [30p] – see page 16 at:

http://siteresources.worldbank.org/INTRUSSIANFEDERATION/Resources/305499-1245838520910/rer19-eng.pdf

 

Website: http://go.worldbank.org/Z61KG4EK20

 

“…..This chapter assesses how the current economic downturn is affecting drug prices and the affordability of medicines, particularly among vulnerable population groups. A related question concerns possible measures that could be adopted in Russia to facilitate access to essential drugs and ensure rational drug use. The chapter focuses on special issues of affordability and access.

 

It also suggests the need for assessing the regulatory role of government in different areas of the pharmaceutical market. Such an assessment would provide policymakers, insurance providers, and healthcare institutions with an analysis of regulation’s impact on efficiency, quality, equity, and cost control….”

 

This chapter was prepared by Patricio V. Marquez, Lead Health Specialist, Europe and Central Asia, World Bank, and Mikhail Bonch-Osmolovskiy, Economist, ECSPE, World Bank, in consultation and with the advice from the following international pharmaceutical specialists: Albert Figueras, Catalan Pharmacological Institute, Barcelona, Spain; Rob Verhage and Wilbert Bannenberg, Health Research for Action (HERA), Suriname and the Netherlands; Martin Auton, Health Action International (HAI), Amsterdam, the Netherlands; Kalipso Chalkidou, National Institute of Health and Clinical Excellence (NICE), London, England; as well as Igor Sheiman, Professor of Health Economics, Higher School of Economics, Moscow, Russia. Additional comments were provided by Andrei Markov, Senior Human Development Specialist; Salman Zaidi, Senior Economist, ECSPE; Willy de Geynd, Lead Health Specialist (ret.); and Sevil Kamalovna Salakhutdinova, Health Specialist, World Bank



 

 *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMS Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.

------------------------------------------------------------------------------------
PAHO/WHO Website


Follow us on Twitter: http://twitter.com/eqpaho

Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.  

[EQ] eHealth for a Healthier Europe - opportunities for a better use of healthcare resources

eHealth for a Healthier Europe!

opportunities for a better use of healthcare resources

This study was conducted by Gartner on behalf of The Ministry of Health and Social Affairs in Sweden 2009

 

Available online as PDF file [84p.] at: http://www.sweden.gov.se/content/1/c6/12/98/15/5b63bacb.pdf



Fact sheet: eHealth for a Healthier Europe!

S2009.026-  July 2009 - Ministry of Health and Social Affairs: http://www.sweden.gov.se/sb/d/2028/a/129808

 

This report is the result of a study conducted by Gartner on behalf of the Swedish Ministry of Health and Social Affairs.

The Ministry launched an initiative in 2008 with the objectives to:

• Make available a concrete example of how to work with a benefits model to analyse how political goals can be realised through eHealth

• Visualize and quantify fact-based benefits of continued implementation of eHealth in the EU

• Give partial support for prioritisation of eHealth initiatives

• Create a stepping stone for further work.

 

"………There is a significant healthcare improvement potential using eHealth as a catalyst. For the five political goals used in the study, the technology adoption is lower than 30%. The potential improvements are of such magnitude that they demand both attention and action from all member states.

 

 Examples of quantified potentials include
:• 5 million yearly outpatient prescription errors could be avoided through the use of Electronic Transfer of Prescriptions.
• 100,000 yearly inpatient adverse drug events could be avoided through Computerised Physician Order Entry and Clinical Decision Support.
  This would in turn free up 700,000 bed-days yearly, an opportunity for increasing throughput and decreasing waiting times,
  corresponding to a value of almost €300 million
• 9 million bed-days yearly
could be freed up through the use of Computer-Based Patient Records,
  an opportunity for either increasing throughput or decreasing waiting times, corresponding to a value of nearly €3,7 billion.

The challenge of locating reliable data was a key issue when performing the study. In medicine, the demand for evidence has always been high and in that light it is paradoxical that key metrics related to healthcare quality, efficiency and availability of care are tracked in a scattered way, if measured at all. Gartner stresses the necessity for each of the member states to:

• Prioritise eHealth initiatives based on political goals and documented benefits
• Improve measurement and collection of healthcare statistics related to eHealth
• Continue to improve and develop present systems, and work on the communication of delivered success
• Develop methods to evaluate, track and reduce medical errors and wastage of resource
• Create a culture, which promotes development and praises success……….."

 

Content:

1. Introduction

2. Challenges for Healthcare

3. Can eHealth Contribute?

4. Methodology

4.1 About the Model

4.2 Robustness

4.3 Caveats

4.4 List of Political Goals, Technologies and Benefits

5. Benefits of eHealth – Overview

5.1 Major Benefits of eHealth

5.2 Major Contributing Technologies

5.3 Findings on Clinical Metrics Availability

6. Benefits of eHealth – Calculations

6.1 Improving Patient Safety

6.2 Increasing Quality of Care

6.3 Increasing Availability

6.4 Increasing Empowerment

7. Conclusions and Recommendations

Appendices

Appendix 1 – Methodology

Appendix 2 – Quantifying Potential Benefits

Appendix 3 – Political Goals

Appendix 4 – Technologies

Appendix 5 – Benefit Details

Swedish Strategy for eHealth. Safe and accessible information in health and social care. Status report 2009

http://www.sweden.gov.se/download/a97569e9.pdf?major=1&minor=124802&cn=attachmentPublDuplicator_0_attachment



 

 *      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMS Area]

"Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members".

------------------------------------------------------------------------------------
PAHO/WHO Website


Follow us on Twitter: http://twitter.com/eqpaho

Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html

 

    IMPORTANT: This transmission is for use by the intended recipient and it may contain privileged, proprietary or confidential information. If you are not the intended recipient or a person responsible for delivering this transmission to the intended recipient, you may not disclose, copy or distribute this transmission or take any action in reliance on it. If you received this transmission in error, please notify us immediately by email to infosec@paho.org, and please dispose of and delete this transmission. Thank you.